Most people assume aging is a single, steady process. In reality, different organ systems age at different rates, and a growing toolkit of biochemical tests can now pinpoint exactly where your body is accelerating—or even reversing—its biological clock. This guide walks you through seven distinct marker categories, explains how each is tested, and shows you how to build a personalized testing protocol that turns raw numbers into meaningful action.
Why Organizing Markers by Category Matters
A single biomarker rarely tells the full story. A multi-nation expert panel convened in 2025 agreed upon a diverse set of aging biomarkers spanning blood chemistry, physical function, and DNA methylation patterns—acknowledging that no single test captures the full picture of biological aging. By grouping markers into functional categories, you can identify which biological systems need attention first and avoid redundant testing that wastes time and money.
Think of each category as a diagnostic lens focused on a different layer of your biology: your DNA's regulatory state, your lipid membranes, your immune signaling, your metabolic machinery, your hormonal balance, your cellular turnover, and your foundational organ health. Tested together over time, they create a multidimensional portrait of aging that no single number can match.
Category 1: Epigenetic Clocks — Measuring Your Aging Velocity
Epigenetic clocks have become the gold standard for quantifying biological age. These algorithms analyze DNA methylation—the addition and removal of methyl groups on your DNA—to estimate either how old your body truly is or how fast it is currently aging.
Key Clocks to Know
- Horvath Clock and Hannum Clock (1st generation): The original epigenetic age estimators, trained on chronological age. They provide a snapshot biological age number but are less responsive to short-term interventions.
- GrimAge (2nd generation): Incorporates surrogate markers for smoking history, inflammation, and metabolic function, making it a powerful predictor of disease onset and mortality.
- DunedinPACE (3rd generation): Rather than estimating total biological age, DunedinPACE measures your rate of aging. A score of 1.0 means you age one biological year per calendar year; below 0.9 indicates slower-than-average aging. It analyzes methylation at 173 specific CpG sites and can respond to interventions within 4–8 weeks.
Research from the Framingham Heart Study demonstrated that DunedinPACE was significantly associated with time to mild cognitive impairment, Alzheimer's disease, and all-cause dementia, with lower DunedinPACE scores linked to greater cognitive resilience. The CALERIE caloric-restriction trial further showed that DunedinPACE was far more responsive to short-term lifestyle changes than older clock algorithms.
How to Get Tested
Epigenetic testing requires a blood draw (not saliva for most validated clocks). Services such as TruDiagnostic offer comprehensive panels that analyze over 900,000 methylation sites and provide biological age estimates for up to 11 organ systems, including brain, heart, liver, kidney, and immune age. Costs typically range from $250 to $800 depending on comprehensiveness. The TruAge COMPLETE panel, for instance, includes DunedinPACE, GrimAge, PhenoAge, Horvath's clock, telomere length, and immune cell composition in a single test.
Category 2: Lipid Biomarkers — Plasmalogens and Brain-Specific Risk
While standard lipid panels measure cholesterol and triglycerides, a deeper layer of lipid biology holds critical clues about brain aging and dementia risk. Plasmalogens—specialized phospholipids concentrated in the brain and heart—are emerging as one of the most revealing biomarkers for cognitive health.
Why Plasmalogens Matter
Plasmalogen levels decline substantially with age. Research shows that the level of plasmalogen in the brain decreases by approximately 40% from age 40 to 70. This decline is not merely a side effect of aging: circulating serum ethanolamine plasmalogen levels are significantly decreased in patients with dementia, and the severity of the decrease mirrors the severity of the dementia.
Data from the Rush University Memory and Aging Project paints a striking picture. An 85-year-old with high plasmalogen levels had only a 5% chance of having dementia, compared to 28% for an 85-year-old with low levels. Perhaps most remarkably, a 95-year-old with high plasmalogen levels had the same likelihood of developing dementia as a 75-year-old with low levels—a finding that underscores how powerfully these lipids may modulate cognitive aging trajectories.
Testing Plasmalogen Levels
Plasmalogen biosynthesis value (PBV) can be measured through specialized blood tests using mass spectrometry-based lipidomics. A higher PBV has been associated with a reduced risk of dementia and improvement across five cognitive domains. While not yet part of routine clinical panels, several specialty laboratories now offer plasmalogen profiling as part of advanced lipid or metabolomic panels.
The Supplementation Connection
Because circulating plasmalogen levels may reflect brain plasmalogen status, measuring serum levels can serve a dual purpose: identifying risk and monitoring the effectiveness of supplementation strategies. Clinical trials in Japan showed that supplemental plasmalogen improved memory in people with Alzheimer's disease, particularly in mild cases and younger patients. Prodrome's plasmalogen supplements are specifically formulated to support lipid biology and provide targeted nutritional support for individuals concerned about cognitive decline and brain health.
Category 3: Inflammatory Markers — The Silent Accelerators
Chronic low-grade inflammation, sometimes called "inflammaging," is one of the primary drivers of biological age acceleration. Testing inflammatory biomarkers can reveal hidden disease risk years before clinical symptoms appear.
Priority Markers
- Interleukin-6 (IL-6): An expert panel identified high IL-6 levels as a key marker associated with heart disease and chronic inflammation. Elevated IL-6 is linked to accelerated epigenetic aging and increased all-cause mortality.
- High-sensitivity C-reactive protein (hs-CRP): A widely available marker of systemic inflammation. Persistently elevated hs-CRP signals increased cardiovascular and neurodegenerative risk.
- Tumor necrosis factor alpha (TNF-α): Elevated in numerous age-related conditions. Trending TNF-α over time reveals whether inflammatory burden is increasing or responding to intervention.
- GlycA: A newer composite marker of systemic inflammation detected via nuclear magnetic resonance spectroscopy. It captures inflammation from multiple protein sources simultaneously.
How to Test
hs-CRP is available through any standard laboratory. IL-6 and TNF-α typically require specialty panels ordered through a longevity-focused physician or direct-to-consumer platforms. Test fasting and at the same time of day for consistency. Repeat every 6–12 months to establish a trend line rather than relying on a single reading.
Category 4: Metabolic and Glycemic Markers
Metabolic health is a cornerstone of biological age. DunedinPACE has been shown to predict incident metabolic syndrome with striking accuracy—one study found that higher baseline DunedinPACE scores were associated with more than 10-fold increased odds of developing metabolic syndrome over a 7.4-year follow-up period.
Essential Tests
- Fasting insulin and glucose: Together, these reveal insulin resistance far earlier than HbA1c alone. The HOMA-IR calculation derived from them is a powerful early-warning metric.
- Hemoglobin A1c (HbA1c): Reflects average blood sugar over 2–3 months. Optimal longevity ranges (below 5.4%) differ from conventional "normal" laboratory ranges.
- Fasting triglyceride-to-HDL ratio: A simple proxy for insulin resistance and cardiovascular risk. A ratio above 2.0 warrants closer investigation.
- Adiponectin: An anti-inflammatory hormone secreted by fat cells. Low levels correlate with insulin resistance, visceral fat accumulation, and accelerated aging.
Standard laboratory reference ranges are statistical constructs based on population data that include unhealthy individuals. For aging-reversal purposes, aim for optimal ranges rather than just "normal" ranges. Work with a practitioner experienced in longevity medicine to interpret results in context.
Category 5: Hormonal and Growth-Factor Signals
Hormones are master regulators of aging. Their decline or dysregulation can cascade into cognitive, metabolic, and cardiovascular deterioration.
Key Markers
- IGF-1 (Insulin-like Growth Factor 1): Identified by expert consensus panels as a predictor of cardiovascular disease and metabolic disorders. Both very high and very low levels carry risk—the goal is an age-appropriate optimal range.
- DHEA-S (Dehydroepiandrosterone sulfate): Declines steadily with age and correlates with immune function, bone density, and cognitive performance.
- Free and total testosterone / estradiol: Relevant for both men and women. Imbalances accelerate sarcopenia, osteoporosis, and cognitive decline.
- Thyroid panel (TSH, free T3, free T4): Subclinical thyroid dysfunction is common in aging and often overlooked in standard screenings.
How to Test
Most hormonal markers are available through standard blood panels. Test in the morning between 7–9 AM when hormonal rhythms are most consistent. For tracking age-reversal interventions, test every 6 months and compare trajectories rather than isolated snapshots.
Category 6: Cellular Senescence and Proteomic Panels
Senescent cells—sometimes called "zombie cells"—accumulate with age and secrete inflammatory molecules that damage surrounding tissue. Biomarkers of cellular senescence have been shown to predict the onset of mobility disability and are reduced by physical activity in older adults.
Emerging Tests
- p16INK4a expression: Measured via specialized blood tests, this is one of the most studied markers of cellular senescence burden.
- Proteomic aging clocks: Services like SomaLogic measure thousands of circulating proteins simultaneously, creating a proteomic age estimate. Multi-omics approaches combining proteomics with epigenetics are yielding increasingly precise biological age measurements.
- Telomere length: While less predictive alone than epigenetic clocks, telomere length provides a complementary measure of cellular aging and replicative capacity. Many epigenetic testing panels now include it.
These tests remain more specialized and costly than standard panels but are becoming more accessible through longevity clinics and direct-to-consumer services. They are most valuable when combined with epigenetic and blood biomarker data for a comprehensive multi-omic portrait.
Category 7: Standard Blood Panels as a Foundation
You do not need to start with expensive specialty tests. CBC, metabolic panels, and lipid panels contain key biomarkers needed for a basic biological age calculation. Many AI-driven platforms can now estimate biological age from standard bloodwork alone, though these estimates are less predictive than epigenetic analysis for long-term aging trajectories.
Foundation Panel Checklist
- Complete blood count (CBC)
- Comprehensive metabolic panel (CMP)
- Standard lipid panel (LDL, HDL, triglycerides, total cholesterol)
- Liver enzymes (ALT, AST, GGT)
- Kidney markers (creatinine, BUN, eGFR)
- Albumin
- Uric acid
These markers are available from any primary care physician and are typically covered by insurance. They serve as your baseline layer—the foundation upon which you add specialized tests as your optimization journey deepens.
Building Your Personal Testing Protocol
Rather than testing everything at once, build a layered protocol based on your goals and budget:
Tier 1: Foundation (Under $200/year)
Request comprehensive blood panels at your annual physical. Include hs-CRP, fasting insulin, HbA1c, and a standard lipid panel. These markers provide an initial aging risk profile that is accessible and affordable.
Tier 2: Targeted Investigation ($200–$500)
Add a plasmalogen lipid profile and advanced inflammatory markers (IL-6, TNF-α). If cognitive health is a primary concern, plasmalogen testing is especially valuable because it provides both risk assessment and a baseline for monitoring supplement interventions like Prodrome's plasmalogen formulations.
Tier 3: Comprehensive Biological Age ($350–$800)
Invest in an epigenetic age test that includes DunedinPACE, GrimAge, and organ-specific age estimates. This is the most powerful single test you can add because it captures your current aging velocity and responds to interventions within weeks rather than months.
Tier 4: Multi-Omic Deep Dive ($800+)
Combine epigenetic testing with proteomic panels and advanced metabolomics for a complete multi-omic portrait. This tier is best suited for individuals working closely with a longevity physician and tracking multiple intervention protocols simultaneously.
Testing Cadence
For intervention tracking, retest your primary markers every 6 months. Epigenetic clocks can be retested every 3–6 months when actively trialing a new protocol. Trends over multiple data points are far more valuable than any single measurement.
Key Takeaways
- No single marker tells the whole story. Combine epigenetic clocks, lipid biomarkers, inflammatory markers, and metabolic panels for a multidimensional picture of aging.
- Epigenetic clocks are the current gold standard. DunedinPACE measures your aging velocity and responds to lifestyle and supplement interventions within weeks.
- Plasmalogens are a critical but underutilized biomarker. Low plasmalogen levels are strongly linked to dementia risk and severity, and they can be both tested and addressed through targeted supplementation.
- Start with standard bloodwork. You can derive meaningful biological age insights from a CBC, metabolic panel, and lipid panel before investing in specialty tests.
- Track trends, not snapshots. Repeat testing at regular intervals to see whether your interventions are actually moving the needle on biological aging.
- Optimal ranges differ from normal ranges. Work with a longevity-focused practitioner who interprets your results against optimal thresholds, not just population averages.
Frequently Asked Questions
What is the most accurate test for biological age?
Epigenetic clocks—particularly DunedinPACE and GrimAge—are currently considered the most accurate and predictive biological age biomarkers. DunedinPACE is especially useful because it measures your rate of aging rather than a static age estimate, making it highly responsive to interventions. For the most comprehensive view, combine an epigenetic test with standard blood biomarkers and a plasmalogen lipid profile.
Can I test for biological age with a standard blood panel?
Yes. A CBC, comprehensive metabolic panel, and lipid panel contain markers that AI-driven platforms can use to estimate biological age. However, these blood-biomarker-based estimates are less predictive of long-term aging trajectories than epigenetic tests. Standard panels are an excellent and affordable starting point, but they measure current health status rather than the deeper epigenetic signals of future disease risk.
What are plasmalogen levels, and why do they matter for brain health?
Plasmalogens are specialized phospholipids essential for neuronal function, antioxidant defense, and cell membrane integrity. Their levels decline by roughly 40% between ages 40 and 70, and low levels are strongly associated with increased dementia risk and severity. Testing your plasmalogen biosynthesis value (PBV) via blood-based mass spectrometry can reveal your cognitive risk profile and establish a baseline for monitoring the effects of plasmalogen supplementation.
How often should I retest my aging biomarkers?
Standard blood panels should be tested at least annually, with hs-CRP and metabolic markers retested every 6 months if you are actively implementing lifestyle or supplement interventions. Epigenetic clocks like DunedinPACE can be retested every 3–6 months during active intervention periods because they are sensitive enough to detect changes within 4–8 weeks.
Can plasmalogen supplements improve my test results?
Clinical research suggests that plasmalogen supplementation can increase plasma plasmalogen levels and may improve cognitive outcomes, particularly in mild Alzheimer's cases. Prodrome's plasmalogen supplements are designed based on lipid biology research to support brain health. Testing your plasmalogen levels before and after supplementation provides an objective way to track the impact of your protocol.
What is the difference between DunedinPACE and GrimAge?
GrimAge estimates your total accumulated biological age and is a strong predictor of disease onset and mortality. DunedinPACE measures the speed at which you are currently aging—your aging velocity. Think of GrimAge as an odometer showing total miles on the engine, while DunedinPACE is the speedometer showing how fast you are driving right now. Both are valuable, and the best testing panels include both.